Encompass Health (EHC)
(Delayed Data from NYSE)
$123.81 USD
-0.85 (-0.68%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $123.76 -0.05 (-0.04%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EHC 123.81 -0.85(-0.68%)
Will EHC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EHC
Here's Why Encompass Health (EHC) is a Strong Growth Stock
Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
EHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Encompass Health Opens New Rehabilitation Hospital in The Villages
Encompass Health Flexes Its Muscle: Margins Widen as Volumes Climb
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
Other News for EHC
Keybanc Raises Price Target for Encompass Health (EHC) to $140 | EHC Stock News
Is EHC building bullish momentum? Slingshot Bullish shows up after slipping 1.1%
Encompass Health (EHC) Receives a Buy from Mizuho Securities
Encompass Health price target raised to $140 from $135 at KeyBanc
Encompass Health price target raised by $5 at KeyBanc, here's why